Press Releases May 1, 2026 08:00 AM

Abacus Chairman and CEO to Speak at the Milken Institute Global Conference in Los Angeles

Abacus CEO to Participate in Prominent Milken Institute Panel on Financial Security

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
ABX

Abacus Global Management announced that its Chairman and CEO, Jay Jackson, will speak at the 2026 Milken Institute Global Conference in Los Angeles. He will participate in a panel discussion focused on private wealth and the future of financial security alongside leaders from major financial institutions.

Abacus Chairman and CEO to Speak at the Milken Institute Global Conference in Los Angeles
ABX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Abacus CEO to speak at a high-profile finance conference, enhancing company visibility.
  • Panel includes influential figures from HSBC Private Bank, Prudential Financial, J.P. Morgan Asset Management, and EQT Group.
  • Abacus specializes in alternative asset management and data-driven wealth solutions emphasizing longevity-based assets and personalized financial planning.

ORLANDO, Fla., May 01, 2026 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NYSE: ABX) today announced that Chairman and CEO Jay Jackson will speak at the 2026 Milken Institute Global Conference. He will join the panel "Private Wealth and the Future of Financial Security" on Monday, May 4, 2026, at 10 a.m. PT.

The panel will be moderated by Maneet Ahuja of ICONOCLAST and Forbes Media and will include leaders from HSBC Private Bank, Prudential Financial, J.P. Morgan Asset Management and EQT Group.

The session can be viewed live at: https://vimeo.com/event/5858036

To request a meeting with Abacus management during the conference, email ir@abacusgm.com.

About Abacus

Abacus Global Management (NYSE: ABX) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide.

For more information, please visit www.abacusgm.com

Contacts:

Investor Relations

Robert F. Phillips – SVP Investor Relations and Corporate Affairs rob@abacusgm.com (321) 290-1198

David Jackson – Managing Director of Investor Relations david@abacusgm.com (321) 299-0716

Abacus Global Management Public Relations press@abacusgm.com


Risks

  • Uncertainty around tangible business impact or immediate growth benefits from the conference appearance.
  • Competitive risks in the financial services sector, especially within alternative asset management and wealth solutions.
  • Market volatility that could impact the performance of longevity-based assets and personalized financial planning sectors.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026